Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

BNT162b2 Vaccine Booster and Mortality Due to Covid-19

by Netzer, Doron , Yaron, Shlomit , Peretz, Alon , Sergienko, Ruslan , Hammerman, Ariel , Arbel, Ronen , Friger, Michael

in Age / Aged / BNT162 Vaccine - immunology / Chronic illnesses / Coronavirus / Coronaviruses / COVID-19 / COVID-19 - mortality / COVID-19 - prevention & control / COVID-19 vaccines / Death / Diabetes / Drug dosages / FDA approval / Female / Humans / Hypertension / Immunization / Immunization, Secondary / Infectious Disease / Israel - epidemiology / Jewish people / Male / Middle Aged / Mortality / Original / Proportional Hazards Models / Regulatory approval / Severe acute respiratory syndrome coronavirus 2 / Sociodemographics / Software / Vaccine Efficacy - statistics & numerical data / Vaccines / Variables

2021

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

BNT162b2 Vaccine Booster and Mortality Due to Covid-19

by Netzer, Doron , Yaron, Shlomit , Peretz, Alon , Sergienko, Ruslan , Hammerman, Ariel , Arbel, Ronen , Friger, Michael

2021

Confirm

Do you wish to request the book?

BNT162b2 Vaccine Booster and Mortality Due to Covid-19

by Netzer, Doron , Yaron, Shlomit , Peretz, Alon , Sergienko, Ruslan , Hammerman, Ariel , Arbel, Ronen , Friger, Michael

2021

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

BNT162b2 Vaccine Booster and Mortality Due to Covid-19

Netzer, Doron,

Yaron, Shlomit,

Peretz, Alon,

Sergienko, Ruslan,

Hammerman, Ariel,

Arbel, Ronen,

Friger, Michael

2021

Overview

Among 843,208 participants in Israel who were 50 years of age or older and had received two doses of the BNT162b2 vaccine at least 5 months earlier, those who received a booster had 90% lower mortality due to Covid-19 than those who did not receive a booster. The study period was 54 days; adverse effects were not recorded.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

Age

/ Aged

/ BNT162 Vaccine - immunology